Plasma and tissue homoarginine concentrations in healthy and obese humans.
Marcus May, Arslan Arinc Kayacelebi, Sandor Batkai, Jens Jordan, Dimitrios Tsikas, Stefan Engeli
Index: Amino Acids 47 , 1847-52, (2015)
Full Text: HTML
Abstract
Increased cardiovascular risk associated with obesity cannot be fully explained by traditional risk markers. We therefore assessed plasma and interstitial concentrations of the novel cardiovascular risk biomarker homoarginine (hArg) in 18 individuals without signs of cardiovascular disease, including 4 morbidly obese subjects before and after bariatric surgery and subsequent weight reduction of 36 ± 7 kg. hArg concentrations were greater in skeletal muscle compared with adipose tissue. Plasma and tissue hArg concentrations did not correlate with BMI. Adipose tissue interstitial hArg concentrations were not affected by obesity, an oral glucose load, or dramatic weight loss. In conclusion, obesity seems not to have a major effect on hArg homeostasis, and hArg may not explain the added cardiovascular risk associated with obesity. Yet, given the small sample size of the study, the significance of hArg in obesity should be investigated in a larger population.
Related Compounds
Related Articles:
2015-04-13
[Biomacromolecules 16(4) , 1382-9, (2015)]
2015-04-15
[Biochem. J. 467(2) , 345-52, (2015)]
2015-05-01
[Biochem. J. 467(3) , 425-38, (2015)]
2015-04-01
[J. Virol. 89(8) , 4421-33, (2015)]
2015-01-01
[Nat. Commun. 6 , 5853, (2015)]